1V209
1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist and has anti-tumor effects. 1V209 can be conjugated with various polysaccharides to improve its water solubility, and enhance its efficacy, and maintain low toxicity[1][2].
Product Specifications
CAS Number
1062444-54-5
Product Name Alternative
TLR7 agonist T7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/1v209.html
Purity
99.67
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(CN2C(NC3=C(N)N=C(OCCOC)N=C23)=O)C=C1
Molecular Formula
C16H17N5O5
Molecular Weight
359.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Battistella C, et al. Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly. Adv Healthc Mater. 2019 Dec;8 (23) :e1901105.|[2]Shinchi H, et al. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides. Bioconjug Chem. 2015 Aug 19;26 (8) :1713-23.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TLR7
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
1211740 100 Pieces/Case:100 Pieces/ PACKS:1 PACKS/CASE
DISC 25MM PCTE 0.2UM THICKER 100/PK
Sign In for Pricing
View Details 
LV748945 1.0 µg DNA
SNRPBP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details